Protara Therapeutics Inc. (TARA)
4.70
-0.33 (-6.56%)
At close: Jan 15, 2025, 3:59 PM
4.71
0.21%
After-hours Jan 15, 2025, 06:21 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -40.42M | -65.95M | -47.25M | -33.98M | -14.99M | -20.73M | -29.96M | -28.53M | -21.38M | -3.34M | -7.91M | -7.97M |
| Depreciation & Amortization | 341.00K | 248.00K | 117.00K | 196.00K | 279.00K | 115.00K | 148.00K | 123.00K | 57.00K | 30.00K | 27.00K | 57.00K |
| Stock-Based Compensation | 6.09M | 6.69M | 10.36M | 9.75M | 943.00K | 3.43M | 925.71 | 3.34M | 2.16M | 459.00K | n/a | n/a |
| Other Working Capital | -4.99M | -92.00K | 494.00K | 431.00K | 625.00K | 190.00K | 4.46M | 1.32M | 359.00K | -846.00K | 183.00K | 320.00K |
| Other Non-Cash Items | 569.00K | 32.02M | 1.74M | 9.94M | -4.00K | -76.00K | 3.39M | 3.69M | 3.57M | -7.25M | 821.00K | 243.00K |
| Deferred Income Tax | n/a | n/a | n/a | -9.94M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | -4.14M | 539.00K | 534.00K | 629.00K | -1.87M | -5.97M | 4.41M | 1.29M | 327.00K | 109.00K | 361.00K | -564.00K |
| Operating Cash Flow | -37.56M | -26.46M | -34.50M | -23.41M | -15.65M | -23.23M | -22.35M | -23.69M | -17.57M | -9.99M | -6.70M | -8.23M |
| Capital Expenditures | -45.00K | -120.00K | -596.00K | -884.00K | -16.00K | -119.00K | -35.00K | -271.00K | -198.00K | -51.00K | -10.00K | -67.00K |
| Acquisitions | n/a | -15.07K | 97.60K | 3.72M | n/a | n/a | n/a | n/a | n/a | n/a | 65.00K | 33.00K |
| Purchase of Investments | -12.19M | -43.55M | -124.75M | n/a | n/a | -15.44M | -32.94M | -39.76M | -88.64M | -34.95M | -3.88M | -8.66M |
| Sales Maturities Of Investments | 65.34M | 58.62M | 27.15M | n/a | 2.50M | 33.99M | 16.88M | 59.94M | 77.51M | 22.52M | 6.55M | 16.07M |
| Other Investing Acitivies | n/a | 15.07K | -97.60K | 3.72M | n/a | n/a | n/a | n/a | 2.01M | n/a | n/a | -1K |
| Investing Cash Flow | 53.11M | 14.95M | -98.19M | 2.83M | 2.48M | 18.43M | -16.10M | 19.92M | -11.33M | -12.48M | 2.73M | 7.38M |
| Debt Repayment | n/a | n/a | n/a | -1.67M | n/a | n/a | n/a | n/a | n/a | n/a | 4.34M | -9.00K |
| Common Stock Repurchased | -91.00K | -90.00K | -228.00K | n/a | n/a | n/a | n/a | 208.00K | 163.00K | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | n/a | n/a | n/a | 103.22M | n/a | 132.00K | 21.52M | n/a | n/a | n/a | n/a | n/a |
| Financial Cash Flow | -91.00K | -90.00K | -228.00K | 189.40M | 500.00K | 2.98M | 23.05M | 208.00K | 163.00K | 88.52M | 4.36M | -9.00K |
| Net Cash Flow | 15.46M | -11.60M | -132.92M | 168.83M | -13.16M | -1.80M | -15.22M | -3.64M | -28.81M | 66.05M | n/a | n/a |
| Free Cash Flow | -37.60M | -26.58M | -35.10M | -24.29M | -15.66M | -23.35M | -22.39M | -23.96M | -17.76M | -10.04M | -6.71M | -8.30M |